Piśmiennictwo

1. Król E., Rutkowski B., Przewlekła choroba nerek – klasyfikacja epidemiologia i diagnostyka. Forum Nefrologiczne 2008;1(1),1-6.
2. NKF K/DOQI Clinical Practice Guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis 2002;39 (2, supl. 1):S1–S266. www.kidney.org/professionals/kdoqi/guidelines_PChN//toc.htm.
3. Levey A.S., Eckhardt K.-U., Tsukamoto Y. i wsp. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67: 2089–2100.
4. Grzegorzewska A. E. Przewlekła choroba nerek (PChN) jako narastający problem w ochronie zdrowia. Probl. Hig. Epidemiol. 2006;87(supl.):124
5. Hood V.L., Tannen R.L. Protection of acid-base balance by pH regulation of acid production. N Engl J Med 1998:819–826.
6. Fall P.J. A stepwise approach to acid-base disorders. Practical patient evaluation for metabolic acidosis and other conditions. Postgrad Med 2000;107:249–250, 253–244, 257–248 passim.
7. Kokot F. Gospodarka wodno-elektrolitowa i kwasowo-zasadowa w stanach fizjologii i patologii. PZWL, Warszawa 2005; s.214.
8. Kraut J.A., Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 2005;45:978–993
9. Yaqoob M.M. Acidosis and progression of chronic kidney disease, Current Opinion In Nephrology and Hypertension 2010, 19:489–492.
10. Ballmer P.E., McNurlan M.A., Hulter H.N. i wsp. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995;95:39–45.
11. Mitch W.E., Du J., Bailey J.L. I wsp. Mechanisms causing muscle proteolysis in uraemia: the in?uence on insulin and cytokines. Miner Electrolyte Metab 1999;25:216–219.
12. Löfberg E., Wernerman J., Anderstam B. I wsp.. Correction of acidosis in dialysis patients increases branched-chain and total essential amino acid levels in muscle. Clin Nephrol 1997;48:230–237.
13. Shah S.N., Abramowitz M., Hostetter T.H. I wsp. Serum bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis 2009; 54:270–277.
14. Menon V., Tighiouart H., Vaughn N.S. i wsp. Serum Bicarbonate and Long-term Outcomesin CKD. Am J Kidney Dis 56:907-914.
15. Myśliwiec M., Małyszko J., Leczenie nefroprotekcyjne, w: Choroby Nerek, red. Myśliwiec M., PZWL, Warszawa 2008, ss.464-484.
16. Steciwko A., Mastalerz-Migas A., Wardyn K.A. Wczesne rozpoznawanie chorób nerek – rola lekarza rodzinnego, w: Choroby Nerek, red. Myśliwiec M., PZWL, Warszawa 2008, ss.625-634.
17. Nath K.A., Hostetter M.K., Hostetter T.H. Pathophysiology of chronic tubulointerstitial disease in rats: interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985;76:667–675.
18. Halperin M.L., Ethier J.H., Kamel K.S. Ammonium excretion in chronic metabolic acidosis: benefits and risks. Am J Kidney Dis 1989;14:267–271.
19. Kohan D.E. Endothelin, hypertension and chronic kidney disease: new insights. Curr Opin Nephrol Hypertens. 2010 19(2):134-9.
20. Wesson D.E., Simoni J., Broglio K. I wsp. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J Physiol Renal Physiol 2011;300:F830–F837.
21. Lyon D.M., Dunlop D.M., Steward C.P. The alkaline treatment of chronic nephritis. Lancet 1931;218:1009–1013.
22. Rustom R., Grime J.S., Costigan M. I wsp. Oral sodium bicarbonate reduces proximal renal tubular peptide catabolism, ammoniogenesis, and tubular damage in renal patients. Ren Fail 1998;20:371–382.
23. Rossier A., Bullani R., Burnier M. i wsp. Bicarbonate de sodium pour ralentir la progression de la maladie rénale chronique. Rev Med Suisse. 2011;7:478-82.
24. Trepiccione F., Zacchia M., Capasso G. The role of the kidney in salt-sensitive hypertension. Clinical and Experimental Nephrology DOI: 10.1007/s10157-011-0489-y
25. Sodium bicarbonate (systemic). Adres: http://www.drugs.com/cons/soda-mint.html
26. Sodium bicarbonate –Compound Summary. Adres: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=516892

Trenuj bez zakwasów

Stosowanie diwęglanu sodu podczas wzmożonego wysiłku fizycznego  więcej ...